Holdings
Farallon Capital Management, L.L.C.
As of Jun 30, 2026, Farallon Capital Management, L.L.C. reported 69 positions worth US$16.1B. Largest: Revolution Medicines, Inc., Electronic Arts Inc. and Bridgebio Pharma, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Revolution Medicines, Inc. | 13.6M | US$2.54B | −54,000 | Jun 30, 2026 |
| Electronic Arts Inc. | 7.92M | US$1.62B | new | Jun 30, 2026 |
| Bridgebio Pharma, Inc. | 10.7M | US$800M | +1.38M | Jun 30, 2026 |
| Protagonist Therapeutics, Inc. | 6.35M | US$778M | no change | Jun 30, 2026 |
| Exelixis, Inc. | 13.5M | US$733M | +357K | Jun 30, 2026 |
| Liquidia Corporation | 8.37M | US$667M | −291K | Jun 30, 2026 |
| Amazon.com, Inc. | 2.63M | US$628M | −1.59M | Jun 30, 2026 |
| Lantheus Holdings, Inc. | 5.58M | US$619M | no change | Jun 30, 2026 |
| Natera, Inc. | 2.22M | US$602M | −989K | Jun 30, 2026 |
| Unitedhealth Group Incorporated | 1.27M | US$528M | −551K | Jun 30, 2026 |